Victor Levenson

5.8k total citations
34 papers, 1.4k citations indexed

About

Victor Levenson is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Victor Levenson has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Victor Levenson's work include Epigenetics and DNA Methylation (15 papers), Cancer Genomics and Diagnostics (9 papers) and RNA modifications and cancer (8 papers). Victor Levenson is often cited by papers focused on Epigenetics and DNA Methylation (15 papers), Cancer Genomics and Diagnostics (9 papers) and RNA modifications and cancer (8 papers). Victor Levenson collaborates with scholars based in United States, Italy and Japan. Victor Levenson's co-authors include Anatoliy A. Melnikov, Thomas Liggett, Joyce L. Hamlin, Irina Davidovich, Denise Scholtens, Igor B. Roninson, Qilong Yi, Andrew K. Godwin, John Rose and Jeffrey R. Marks and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Cancer.

In The Last Decade

Victor Levenson

34 papers receiving 1.4k citations

Peers

Victor Levenson

ONCOL

GENET

PRM

Luke Hughes‐Davies United Kingdom

Kimberly H. Kim United States

Scott K. Thompson United States

Gaofeng Xiong United States

Chia-Lung Tsai Taiwan

Nagarajan Kannan United States

Christopher N. Parris United Kingdom

Michael Gonzalez United Kingdom

Say Li Kong Singapore

Meihua Song United States

Luke Hughes‐Davies United Kingdom

Victor Levenson

1.5k ×1.4

505 ×0.9

540 ×1.5

ONCOL

468 ×2.9

GENET

180 ×1.2

PRM

Citations per year, relative to Victor Levenson Victor Levenson (= 1×) peers Luke Hughes‐Davies

Countries citing papers authored by Victor Levenson

Since Specialization

Citations

This map shows the geographic impact of Victor Levenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Levenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Levenson more than expected).

Fields of papers citing papers by Victor Levenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Levenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Levenson. The network helps show where Victor Levenson may publish in the future.

Co-authorship network of co-authors of Victor Levenson

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Levenson. A scholar is included among the top collaborators of Victor Levenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Levenson. Victor Levenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perez, Ricardo E., et al.. (2020). Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biology & Therapy. 21(11). 1033–1040. 7 indexed citations

Li, Yan, Anatoliy A. Melnikov, Victor Levenson, et al.. (2015). A seven-gene CpG-island methylation panel predicts breast cancer progression. BMC Cancer. 15(1). 417–417. 31 indexed citations

Duan, Lei, Guoguang Ying, Ricardo E. Perez, et al.. (2014). The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT. Journal of Biological Chemistry. 289(31). 21694–21705. 13 indexed citations

Duan, Lei, et al.. (2014). Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells. Cancer Letters. 353(2). 290–300. 23 indexed citations

Ogawa, Takenori, Thomas Liggett, Anatoliy A. Melnikov, et al.. (2012). Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance. Cell Cycle. 11(8). 1656–1663. 51 indexed citations

Cassinotti, Elisa, Joshua Melson, Thomas Liggett, et al.. (2011). DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. International Journal of Cancer. 131(5). 1153–1157. 73 indexed citations

Liggett, Thomas, Anatoliy A. Melnikov, Qilong Yi, et al.. (2010). Differential methylation of cell‐free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 116(7). 1674–1680. 104 indexed citations

Duan, Lei, et al.. (2010). Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-induced Cytotoxicity in Estrogen Receptor-positive Breast Cancer Cells. Journal of Biological Chemistry. 286(4). 2864–2876. 34 indexed citations

Liggett, Thomas, Anatoliy A. Melnikov, Qilong Yi, et al.. (2010). Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecologic Oncology. 120(1). 113–120. 95 indexed citations

10.

Levenson, Victor. (2010). DNA methylation as a universal biomarker. Expert Review of Molecular Diagnostics. 10(4). 481–488. 122 indexed citations

11.

Liggett, Thomas, Anatoliy A. Melnikov, Qilong Yi, et al.. (2010). Methylation patterns of cell-free plasma DNA in relapsing–remitting multiple sclerosis. Journal of the Neurological Sciences. 290(1-2). 16–21. 76 indexed citations

12.

Sepulveda, Antonia R., Dan Jones, Shuji Ogino, et al.. (2009). CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics. Journal of Molecular Diagnostics. 11(4). 266–278. 39 indexed citations

13.

Melnikov, Anatoliy A., Denise Scholtens, Andrew K. Godwin, & Victor Levenson. (2008). Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma. Journal of Molecular Diagnostics. 11(1). 60–65. 77 indexed citations

14.

Melnikov, Anatoliy A., Denise Scholtens, Marina Talamonti, David J. Bentrem, & Victor Levenson. (2008). Methylation profile of circulating plasma DNA in patients with pancreatic cancer. Journal of Surgical Oncology. 99(2). 119–122. 66 indexed citations

15.

Levenson, Victor. (2007). Biomarkers for early detection of breast cancer: What, when, and where?. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(6). 847–856. 109 indexed citations

16.

Davidovich, Irina, Anait S. Levenson, & Victor Levenson. (2004). Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance. Cancer Letters. 211(2). 189–197. 16 indexed citations

17.

Dijkwel, Peter A., Larry D. Mesner, Victor Levenson, Joseph A. D'Anna, & Joyce L. Hamlin. (2000). Dispersive Initiation of Replication in the Chinese Hamster Rhodopsin Locus. Experimental Cell Research. 256(1). 150–157. 33 indexed citations

18.

Levenson, Victor, Ekkehart Lausch, Eugenia V. Broude, et al.. (1999). A Combination of Genetic Suppressor Elements Produces Resistance to Drugs Inhibiting DNA Replication. Somatic Cell and Molecular Genetics. 25(1). 9–26. 21 indexed citations

19.

Levenson, Victor, et al.. (1998). Internal Ribosomal Entry Site-Containing Retroviral Vectors with Green Fluorescent Protein and Drug Resistance Markers. Human Gene Therapy. 9(8). 1233–1236. 28 indexed citations

20.

Levenson, Victor & Joyce L. Hamlin. (1993). A general protocol for evaluating the specific effects of DNA replication inhibitors. Nucleic Acids Research. 21(17). 3997–3404. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact